'The FDA and Merck have essentially engaged the public in a gamble without public debate,' argues Stanford University's michaelzlin.
as a"gamechanger" in the fight against the deadly global pandemic, and the Food and Drug Administration decided last week to authorize the treatment on an emergency-use basis for certain segments of the U.S. population.
Lin noted that while"we are already familiar with the fact that viruses naturally mutate to evade immunity... molnupiravir relies on inducing even more mutations so that eventually the virus' proteins are damaged beyond function. That molnupiravir can mutate SARS-CoV-2 to death has been demonstrated in the controlled conditions of a petri dish and lab animal cages, leading Merck to test it in covid-19 patients in clinical trials.
Lin's concerns about molnupiravir's capacity to generate new coronavirus variants could hardly be characterized as fringe alarmism, given the chorus of expert voices raising similar objections to the treatment.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
FDA says rapid Covid antigen tests may be less sensitive in detecting omicronThe Food and Drug Administration said Tuesday that preliminary research shows some rapid antigen tests may be less sensitive at detecting the highly contagious omicron variant of the coronavirus.
Baca lebih lajut »
FDA-approved Vuity eyedrops could replace your reading glassesHow do Vuity eyedrops work? How much do they cost? Experts discuss what consumers should know about FDA-approved product.
Baca lebih lajut »
High demand, low supply postpones 'miracle' FDA-approved weight loss drug to mid-2022The first FDA-approved weight loss drug since 2014 will not be available to consumers due to manufacturing and delivery issues.
Baca lebih lajut »
FDA: Rapid Tests May Not Be the Best at Detecting OmicronThe FDA warned Tuesday that those relying on a rapid test to see if they’ve contracted COVID-19 should double down on them.
Baca lebih lajut »
FDA Says Rapid Tests at Home Have ‘Reduced Sensitivity’ for OmicronWhile rapid antigen tests have always been less accurate than molecular PCR tests, many Americans have relied on them for their convenience to determine if they’re at risk of spreading the virus
Baca lebih lajut »